These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9132801)

  • 1. [Polysaccharide vaccines. II. Meningococcal vaccines].
    Wysokińska T; Janaszek W
    Przegl Epidemiol; 1996; 50(4):425-9. PubMed ID: 9132801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of bacterial meningitis in Niamey, Niger, 1981-96.
    Campagne G; Schuchat A; Djibo S; Ousséini A; Cissé L; Chippaux JP
    Bull World Health Organ; 1999; 77(6):499-508. PubMed ID: 10427935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of meningococcal meningitis in children in France].
    Levy C; Taha MK; Weill Olivier C; Quinet B; Lécuyer A; Alonso JM; Cohen R; Bingen E;
    Arch Pediatr; 2008 Dec; 15 Suppl 3():S105-10. PubMed ID: 19268239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meningitis and encephalitis in 1997].
    Zabicka J
    Przegl Epidemiol; 1999; 53(1-2):57-66. PubMed ID: 10402851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing meningitis.
    Selekman J
    Pediatr Nurs; 2003; 29(6):467-9. PubMed ID: 14743845
    [No Abstract]   [Full Text] [Related]  

  • 6. [Meningitis and encephalitis in Poland in 2007].
    Lankiewicz A; Polkowska A; Chrześcijańska I; Kicman-Gawłowska A; Stefanoff P
    Przegl Epidemiol; 2009; 63(2):199-202. PubMed ID: 19799245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.
    Parent du Châtelet I; Traore Y; Gessner BD; Antignac A; Naccro B; Njanpop-Lafourcade BM; Ouedraogo MS; Tiendrebeogo SR; Varon E; Taha MK
    Clin Infect Dis; 2005 Jan; 40(1):17-25. PubMed ID: 15614687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningitis and encephalitis in Poland in 2005].
    Stefanoff P; Rosińska M
    Przegl Epidemiol; 2007; 61(2):225-34. PubMed ID: 17956036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoprophylaxis and vaccine for prevention of bacterial meningitis in children].
    Bourrillon A; Bingen E
    Rev Prat; 2004 May; 54(9):973-8. PubMed ID: 15296275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
    Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
    Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meningitis and encephalitis in Poland in 2006].
    Kicman-Gawłowska A; Chrześcijańska I; Stefanoff P
    Przegl Epidemiol; 2008; 62(2):253-60. PubMed ID: 18807466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Trends of etiology of acute bacterial meningitis in Chilean children from 1989 to 1998. Impact of the anti-H influenzae type b vaccine].
    Díaz JM; Catalán L; Urrutia MT; Prado V; Ledermann W; Mendoza C; Topelberg S
    Rev Med Chil; 2001 Jul; 129(7):719-26. PubMed ID: 11552439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningitis vaccine approved for younger children.
    Child Health Alert; 2007 Dec; 25():2. PubMed ID: 20461858
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bacterial meningitis caused by Neisseria meningitidis. Prophylactic measures].
    Magdzik W
    Przegl Epidemiol; 2004; 58(2):241-51. PubMed ID: 15521103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of the heptavalent pneumococcal vaccine against meningitis, pneumonia and acute otitis media in pediatric age. Theoretical coverage offered by the heptavalent conjugate vaccine in Italy].
    Principi N; Esposito S
    Ann Ig; 2002; 14(6 Suppl 7):21-30. PubMed ID: 12638361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugate vaccines--a breakthrough in vaccine development.
    Mäkelä PH
    Southeast Asian J Trop Med Public Health; 2003 Jun; 34(2):249-53. PubMed ID: 12971544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].
    Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ
    Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serogroup C meningococcal conjugate vaccines: new preparations. Effective from age two months.
    Prescrire Int; 2003 Apr; 12(64):43-6. PubMed ID: 12675020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.